The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
As the prevalence and impact of anemia in patients with cancer have been recognized, clinical guidelines with recommendations for the use of both transfusions and recombinant human erythropoietin (rHuEPO; epoetin alfa) are continuing to evolve. The strength of recommendations varies depending on the availability of randomized, controlled clinical trial data for a given endpoint, which can include...
Anemia is common in cancer patients during chemotherapy. The study discussed in this article was primarily designed to assess the effects of epoetin alfa on transfusion requirements, hematopoietic response, quality of life (QOL), and safety in cancer patients receiving nonplatinum-based chemotherapy under randomized, double-blind, placebo-controlled conditions. Over the course of the study, a growing...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.